top of page

PEER-REVIEWED PUBLICATIONS (> 4700 citations, h-index = 31)

(*Authors contributed equally, #corresponding author)​


47.    Jeonghyun Moon, May Phoo, James Moon, Sejin Son#.

10.    Designing of Polysaccharide Immunoadjuvant for Vaccine and Immunotherapy.

10.    Progress in Materials Science (IF=37.4, Top 1.60%), Submitted

46.    Juwon Baig*, Hyemin Cho, Weihsuan Chen, Gahyun Lee, and Sejin Son#.

10.    Emerging Mechanisms in Immunoadjuvant Design for Vaccine and Immunotherapy.

10.    Trends in Pharmaceutical Sciences (IF=13.8, Top 2.00%), In Revision

45.    오재은*, 손세진#

10.    폴리사카라이드 (POLYSACCHARIDE) 기반 면역활성제를 통한 백신 및 면역 치료제의 개발

10.    한국생물공학회, BT news,

44.    Jutaek Nam*, April Kim*, Kidong Kim*, Jung Hyun Moon, Juwon Baig, May Phoo, James Moon# and Sejin Son#.

10.    Engineered Polysaccharides for Controlling the Innate and Adaptive Immune Responses.

10.    Nature Reviews Bioengineering

43.    Aliya Sheik, Kugalur Shangmugam Ranjith, Seyed Majid Ghoreishian, Yujeong Yang, YongHyeon Park, Sejin Son, Young-Kyu Han, Yun Suk

10.    Huh.

10.    Green approach for the fabrication of dual-functional S/N doped graphene tagged ZnO nanograins for in vitro bioimaging and water

10.    pollutant remediation.

10.    Environmental Pollution, 343,123077. (IF=8.9, Top 10.00%)


42.    Ivan Hardianto Suliman, Ki Dong Kim, Wei Hsuan Chen, Yu Bin Kim, Jeong Hyun Moon, Sejin Son#, Jutaek Nam#.

10.    Metal-Based Nanoparticles for Cancer Metalloimmunotherapy.

10.    Pharmaceutics,15(7), 2003. (IF=5.4, Top 13.80%)   

41.    Deborah Lee, Seoyoon Song, Suheon Kim, Mina Lee, Eunsu Kim, Sunhee Yoon, Han-Ul Kim, Sejin Son, Hyun Suk Jung, Yun Suk Huh, Sun

10.    Min Kim#, and Tae-Joon Jeon#.

10.    Multicomponent-Loaded Vesosomal Drug Carrier for Controlled and Sustained Compound Release.

10.    Biomacromolecules, 24, 8, 3898–3907. (IF=6.2, Top 4.46%)

40.    Isra Rana, Jaeeun Oh, Juwon Baig, Jeonghyun Moon, Sejin Son#, Jutaek Nam#.

10.    Nanocarriers for cancer nano-immunotherapy

10.    Drug Delivery and Translational Research, 13, 1936-1954. (IF=5.4, Top 20.97%)

39.    Sejin Son*# Jutaek Nam*, April S. Kim, Jinsung Ahn, Kyung Soo Park, May Thazin Phoo, Brett Sherren, Weiping Zou, Soo-Hong Lee, Omid C.

10.    Farokhzad, Jinjun Shi, James J. Moon#.

10.    Induction of T-helper-17-cell-mediated anti-tumour immunity by pathogen-mimicking polymer nanoparticles.

10.    Nature Biomedical Engineering, 7, 72-84. (IF=28.1, Top 0.51%)

10.    Highlighted in Nature BME News & Views

10.    -"TH17 cells boosted by nanoparticle-bound fungal motifs" by Mihai G. Netea & Williem J.M. Mulder​.



Before INHA University ---------------------------------------------------------------------------------------------------------------------------------------------------

38.    Nam J*, Son S*, Park K, Moon JJ.

10.    Photothermal therapy combined with neoantigen cancer vaccination for effective immunotherapy against large established tumors and

10.    distant metastasis.

10.    Advanced Therapeutics, 2100093. (IF=4.6, Top 25.40%)

37.    Park K, Nam J, Son S, Moon JJ.

10.    Personalized combination nano-immunotherapy for robust induction and tumor infiltration of CD8+ T cells.

10.    Biomaterials, 274, 120844. (IF=14, Top 1.32%)

36.    Park K, Bazzill J, Son S, Nam J, Shin SW, Stuckey J, Meagher J, Song J, Montefiori DC, LaBranche CC, Smith J, Xu J, and Moon JJ.

10.    Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2.

10.    Journal of Controlled Release, 330, 529-539. (IF=10.8, Top 3.51%)

35.    Nam J*, Son S*, Park K, Moon JJ.

10.    Modularly programmable nanoparticle vaccine based on polyethyleneimine for personalized cancer immunotherapy.

10.    Advanced Science, 8 (5), 2002577. (IF=15.1, Top 4.94%)


34.    Scheetz L, Kadiyala P, Sun X, Son S, Najafabadi A, Aikins M, Lowenstein P, Schwendeman A, Castro M, and Moon JJ.

10.    Synthetic high-density lipoprotein nanodiscs for personalized immunotherapy against gliomas.

10.    Clinical Cancer Research, 26, 16, 4369-4380. (IF=11.5, Top 8.90%)

33.    Son S*, Nam J*, Zenkov I, Ochyl LJ, Xu Y, Scheetz L, Shi J, Farokhzad OC# Moon JJ#.

10.    Sugar-Nanocapsules imprinted with Microbial Molecular Patterns for mRNA Vaccination.

10.    Nano Letters, 20, 3, 1499-1509. (IF=10.8, Top 5.74%)


32.    Nam J*, Son S*, Park KS, Moon JJ.

10.    Cancer nanomedicine for the new era of combination cancer therapy.

10.    Nature Review Materials, 4 (6), 398-414. (IF=83.5, Top 0.18%)


31.    Kuai R*, Yuan W*, Son S, Nam J, Xu Y, Fan Y, Schwendeman A, and Moon JJ.

10.    Elimination of established tumors with nanodisc-based combination chemoimmunotherapy.

10.    Science Advances, 4, eaao1736. (IF=13.6, Top 5.07%)

30.    Nam J*, Son S*, Ochyl LJ, Kuai R, Schwendeman A, Moon JJ.

10.    Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer.

10.    Nature Communication, 9, 1074. (IF=16.6, Top 3.91%)


29.    You DG, Yoon HY, Jeon S, Um W, Son S, Park JH, Kwon IC, Kim K.

10.    Deep tissue penetration of nanoparticles using pulsed-high intensity focused ultrasound.

10.    Nano convergence, 4, 30. (IF=11.7, Top 7.20%)

28.    Nam J, Son S, JJ Moon.

10.    Adjuvant-loaded spiky gold nanoparticles for activation of innate immune  cells.

10.    Cellular and molecular bioengineering, 10, 341-355. (IF=2.8, Top 71.53%)

27.    Son S*, Kim N*, You DG, Yoon HY, Yhee JY, Kim K, Kwon IC, Kim SH.

10.    Antitumor therapeutic application of self-assembled RNAi-AuNP nanoconstructs: Combination of VEGF-RNAi and photothermal ablation.

10.    Theranostics, 7, 9. (IF=12.4, Top 6.85%)


26.    Min HS*, Son S*, You DG, Lee TW, Lee S, Lee J, Han MH, Park JH, Kim SH, Choi K, Park K, Kim,  K, Kwon IC.

10.    Chemical gas-generating nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug delivery.

10.    Biomaterials, 108, 57. (IF=14, Top 1.52%)

25.    Han H*, Son S*, Son S, Kim N, Yhee JY, Lee JH, Choi JS, Joo CK, Lee H, Kim WJ, Kim SH, Kwon, IC, Kim H, Kim K.

10.    Reducible polyethylenimine nanoparticles for efficient siRNA delivery in corneal neovascularization therapy.

10.    Macromolecular Bioscience, 16, 11, 1583, Highlighted in Cover Picture. (IF=4.6, Top 12.80%)

24.    You DG, Deepagan VG, Um W, Jeon S, Son S, Chang H, Yoon HI, Cho YW, Swierczewska M, Lee S, Pomper MG, Kwon IC, Kim K, Park JH.        10.    ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer.

10.    Scientific Reports, 6, 23200. (IF=4.6, Top 7.89%)


23.    Min HS, You DG, Son S, Jeon S, Yhee J, Park JH, Lee S, Kwon IC, Kim K.

10.    Echogenic glycol chitosan nanoparticles for ultrasound-triggered cancer theranostics.

10.    Theranostics. Highlighted in Cover Picture, 5, 12, 1402-1418. (IF=12.4, Top 6.85%)

22.    Yhee JY, Son S, Lee H, Kim K.

10.    Nanoparticle-based combination therapy for cancer treatment.

10.    Current Pharmaceutical Design, 21, 22, 3158-66. (IF=3.1, Top 24.41%)


21.    Yhee JY, Song S, Lee SJ, Park S, Kim K, Kim MG, Son S, Koo H, Kwon IC, Jeong JH, Jeong SY, Kim SH, Kim K.

10.    Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance.

10.    Journal of Controlled Release, 198, 28, 1-9. (IF=10.8, Top 3.64%)

20.    Yoon HY*, Son S*, Lee SJ, You DG, Yhee JY, Park JH, Swierczewska M, Lee S, Kwon IC, Kim SH, Kim K, Promper MG.

10.    Glycol chitosan nanoparticles as highly specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA.

10.    Scientific Reports, 4, 6878. (IF=4.6, Top 13.39%)

19.    Son S*, Min HS*, You DG, Kim BS, Kwon IC.

10.    Echogenic nanoparticles for ultrasound technologies; evolution from diagnostic imaging modality to multimodal theranostic agent.

10.    Nano Today, 9, 4, 525-540. (IF=17.4, Top 1.45%)

18.    Son S*, Nam J*, Kim J, Kim S, Kim WJ.

10.    i-motif-driven Au nanomachines in programmed siRNA delivery for gene-silencing and photothermal ablation.

10.    ACS Nano, 8, 6, 5574-5584. (IF=17.1, Top 3.14%)


17.    Yhee JY, Lee SJ, Lee S, Song S, Min HS, Kang, SW, Son S, Jeong SY, Kim SH, Kim K.

10.    Tumor-targeting Transferrin Nanoparticles for Systemic Polymerized siRNA Delivery in Tumor-bearing Mice.

10.    Bioconjugate Chemistry, 24, 11, 1850-1860. (IF=4.7, Top 13.39%)

16.    Min HS*, Son S*, Lee TW, Koo, H, Yoon HY, Na JH, Choi Y, Park JH, Lee J, Han M, Park RW, Kim IS, Jeong SY, Kim SH, Kwon IC, Kim K.

10.    Liver-specific and echogenic hyaluronic acid nanoparticles facilitating liver cancer discrimination.

10.    Advanced Functional Materials, 23, 44, 5518-5529, Highlighted in Cover Picture. (IF=19, Top 4.09%)

15.    Lee SJ*, Son S*; Yhee JY, Choi K, Kwon IC, Kim SH, Kim K.

10.    Structural modification of siRNA for efficient gene silencing.

10.    Biotechnology Advances, 31, 5, 491-503. (IF=16, Top 2.22%)


14.    Park J, Singha K, Son S, Kim J, Namgung R, Yun CO, Kim WJ.

10.    A Review of RGD-functionalize non-viral gene delivery vectors for cancer therapy.

10.    Cancer Gene Therapy, 19, 741-748. (IF=6.4, Top 20.31%)

13.    Son S*, Namgung R, Kim J, Singha K, Kim WJ.

10.    Bioreducible polymers for gene silencing and delivery.

10.    Account of Chemical Research, 45, 1100-1112. (IF=18.3, Top 1.70%)

12.    Joung YK*, Son S*, Jang JY, Kwon MH, Park KD.

10.    Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.

10.    Pharmaceutical Research, 29, 932-942. (IF=3.7, Top 12.90%)​



11.    Son S*, Kim G, Singha K, Park S, Ree M, Kim WJ.

10.    Artificial Cell Membrane-mimicking Nanostructure Facilitates Efficient Gene Delivery through Fusogenic Interaction with the Plasma              10.    Membrane of Living Cells.

10.    Small, 7, 2991-2997, Highlighted  in the frontispiece. (IF=13.3, Top 5.84%)

10.    Che HL, Muthiah M, Ahn Y, Son S, Kim WJ, Seonwoo H, Chung JH, Cho CS, Park IK.

10.    Biodegradable Particulate Delivery of Vascular Endothelial Growth Factor Plasmid from Polycaprolactone/Polyethylenimine Electrospun    10.    Nanofibers for the Treatment of Myocardial Infarction.

10.    Journal of Nanoscience and Nanotechnology, 11, 1-5. (IF=1.134, Top 39.95%)

9.       Hwang DW, Son S, Jang J, Youn H, Lee S, Lee D, Lee YS, Jeong JM, Kim WJ, Lee DS.

1.       A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA.

1.       Biomaterials, 32, 4968-4975. (IF=14, Top 2.00%)

8.       Garripelli VK, Kim JK, Son S, Kim WJ, Repka MA, Jo S.

1.       Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery.

1.       Acta Biomaterialia, 7, 1984-1992. (IF=9.7, Top 4.24%)

7.       Son S*, Hwang DW, Singha K, Jeong JH, Park TG, Lee DS, Kim WJ.

1.       RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain.

1.       Journal of Controlled Release, 155, 18-25. (IF=10.8, Top 5.70%)

6.       Yang SY*, Son S*, Jang S, Kim H, Jeon G, Kim WJ, Kim JK.

1.       DNA-functionalized nanochannels for SNP detection.

1.       Nano Letters, 11, 1032-1035. (IF=10.8, Top 3.04%)

5.       Son S*, Singha K, Kim WJ.

1.       Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrier.

1.       Biomaterials, 31, 6344-6354. (IF=14.0, Top 2.00%)​


4.       Kim G, Rho Y, Park S, Kim H, Son S, Kim H, Kim IJ, Kim JR, Kim WJ, Ree M.

1.       The biocompatibility of self-assembled brush polymers bearing glycine derivatives.

1.       Biomaterials, 31, 3816-3826. (IF=14.0, Top 2.50%)

3.       Son S*, Kim WJ.

1.       Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery.

1.       Biomaterials, 31, 133-143. (IF=14.0, Top 2.50%)


​2.       Namgung R, Nam S, Kim SK, Son S, Singha K, Kwon JS, Ahn Y, Jeong MH, Park IK, Garripelli VK, Jo S, Kim WJ.

1.       An acid-labile temperature-responsive sol-gel reversible polymer for enhanced gene delivery to the myocardium and skeletal muscle cells.

1.       Biomaterials, 30, 5225-5233. (IF=14.0, Top 3.12%)

1.       Son S*, Lee WR, Joung YK, Kwon MH, Kim YS, Park KD.
1.       Optimized stability retention of a monoclonal antibody in the PLGA nanoparticles.

1.       International Journal of Pharmaceutics, 368,178-185. (IF=5.8, Top 38.29%)


bottom of page